secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viridian Therapeutics, Inc.\DE (VRDN)
CIK:        0001590750
Form:       8-K
Filed at:   2026-06-03T11:00:22+00:00
Accession:  0001193125-26-254560
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Viridian Therapeutics Annual Meeting approves director elections, KPMG ratification, say-on-pay
--------------------------------------------------------------------------------

- Tomas Kiselak and Jennifer K. Moses elected as Class II directors until 2029.
- KPMG LLP ratified as independent auditor for FY2026; 92.9M for, 0.5M against.
- Advisory say-on-pay approved with 83.5M for, 3.1M against.
- Board sets future say-on-pay votes every year based on advisory vote results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590750/000119312526254560/0001193125-26-254560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590750/000119312526254560/d117727d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-254560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer